Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Martin (1953)
Involvement of autonomic nerve-fibres in diabetic neuropathy.Lancet, 1 6760
L. Heding, U. Larsen, J. Markussen, K. Jørgensen, O. Hallund (1988)
Radioimmunoassays for Human, Pork and Ox C-peptides and Related Substances
G. Molnar, V. Fatourechi, E. Ackerman, W. Taylor, J. Rosevear, L. Gatewood, F. Service, K. Moxness (1971)
Growth hormone and glucose interrelationships in diabetes: studies of inadvertent hypoglycemic episodes during continuous blood glucose analysis.The Journal of clinical endocrinology and metabolism, 32 3
R. Rundles (1945)
DIABETIC NEUROPATHY: General Review with Report of 125 CasesMedicine, 24
P. Sönksen, M. Srivastava, C. Tompkins, J. Nabarro (1972)
Growth-hormone and cortisol responses to insulin infusion in patients with diabetes mellitus.Lancet, 2 7769
(1976)
Defective hypoglycaemia counter-regulation during physiological insulin infusion
B. Murphy (1967)
Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.The Journal of clinical endocrinology and metabolism, 27 7
(1969)
Radioimmunoassay of growth hormone
R. Russell, James Thomson, S. Bloom (1974)
The effect of truncal and selective vagotomy on the release of pancreatic glucagon, insulin and enteroglucagonBritish Journal of Surgery, 61
L. Campbell, E. Kraegen, L. Lazarus (1977)
Defective blood glucose counter-regulation in diabetics is a selective form of autonomic neuropathy.British Medical Journal, 2
E. Kraegen, L. Lazarus, H. Meler, L. Campbell, Y. Chia (1975)
Carrier solutions for low-level intravenous insulin infusion.British Medical Journal, 3
S. Bloom, N. Vaughan, R. Russell (1974)
Vagal control of glucagon release in man.Lancet, 2 7880
(1978)
Evaluation of hormonal and metabolic events following insulin induced hypoglycaemia
Dissociated a and / 3 cell responses in permanent pancreatic autotransplants
L. Campbell, G. Smythe, L. Lazarus, E. Kraegen (1977)
BIOGENIC AMINES and GLUCAGON RELEASEAustralian and New Zealand Journal of Medicine, 7
R. Chochinov, W. Daughaday (1975)
Marked Hyperthermia as a Manifestation of Hypoglycemia in Long-standing Diabetes MellitusDiabetes, 24
George Smythe, L. Lazarus (1973)
Growth Hormone Regulation by Melatonin and SerotoninNature, 244
J. Plonk, C. Bivens, J. Feldman (1974)
Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadine.The Journal of clinical endocrinology and metabolism, 38 5
(1978)
Role of blood glucose concentration in the hormonal control of hepatic glucose production in vivo: evidence of autoregulation by glucose
A. Gordon, B. Meldrum (1970)
Effect of insulin on brain 5-hydroxytryptamine and 5-hydroxy-indole-acetic acid of rat.Biochemical pharmacology, 19 12
M. Serio, B. Tarquini, P. Contini, A. Bucalossi, R. Toccafondi (1968)
Plasma Cortisol Response to Insulin and Circadian Rhythm in Diabetic SubjectsDiabetes, 17
G. Reaven, A. Silvers, J. Farquhar (1970)
Study of the Relationship Between Plasma Insulin Concentration and Efficiency of Glucose Uptake in Normal and Mildly Diabetic SubjectsDiabetes, 19
K. Alberti, T. Hockaday (1973)
Diabetic coma: Serum growth hormone before and during treatmentDiabetologia, 9
125 16 16 6 6 L. V. Campbell E. W. Kraegen H. Meler L. Lazarus Garvan Institute of Medical Research St. Vincent's Hospital Sydney Australia Summary Twenty diabetic patients and fourteen normal volunteers received infusion of 2.4 U neutral porcine insulin/h until either the blood glucose level was stable, or until hypoglycaemia occurred. As previously reported (1) in the normal group the blood glucose stabilised at 2.8±0.1 mmol/l without any hypoglycaemic symptoms. There was an increase in blood levels of glucagon, cortisol and growth hormone as the blood glucose level fell, the mean peak increments being 167±33 pg/ml, 400±71 nmol/l and 29±7 mU/l, respectively. In ten of the diabetic subjects (Group A) the blood glucose level stabilised at 3.6±0.2 mmol/l during the insulin infusion, with peak increments in plasma glucagon (110±24pg/ml), cortisol (411±71 nmol/l) and growth hormone (22±6 mU/l), not significantly different from those in the normal subjects. These rises in hormone levels occurred during the last hour of infusion after normoglycaemia was reached and maintained. The ten remaining diabetics (Group B) developed symptoms of hypoglycaemia during the infusion. The peak increments in plasma glucagon (19±7 pg/ml), cortisol (183±36 nmol/l) and growth hormone (6±2 mU/l) in this latter group were significantly less than those in the other diabetic group or the normals. The absence of counter-regulatory hormonal responses in the Group B diabetics was related to the development of hypoglycaemia and may be the result of a dysfunction of hypothalamic gluco-regulatory centres.
Diabetologia – Springer Journals
Published: Jun 1, 1979
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.